Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 767,565 |
|
|||||
| News | - | ||||||
| Day High | 6.56 | Low High |
|||||
| Day Low | 6.18 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Travere Therapeutics Inc | TVTX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.10 | 1.62% | 6.26 | 18:59:15 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 6.44 | 6.18 | 6.56 | 6.26 | 6.16 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,770 | 767,565 | US$ 6.31 | US$ 4,843,420 | - | 5.12 - 19.5424 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:30:08 | 1 | US$ 6.47 | USD |
Travere Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 476.38M | 76.10M | - | 145.24M | -111.4M | -1.46 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Travere Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TVTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.40 | 6.56 | 5.21 | 5.70 | 1,458,205 | 0.86 | 15.93% |
| 1 Month | 6.84 | 7.26 | 5.12 | 6.04 | 1,448,086 | -0.58 | -8.48% |
| 3 Months | 8.34 | 9.03 | 5.12 | 7.16 | 1,262,944 | -2.08 | -24.94% |
| 6 Months | 6.68 | 10.27 | 5.12 | 7.60 | 1,442,397 | -0.42 | -6.29% |
| 1 Year | 15.41 | 19.5424 | 5.12 | 10.10 | 1,419,320 | -9.15 | -59.38% |
| 3 Years | 25.15 | 31.65 | 5.12 | 16.86 | 1,091,836 | -18.89 | -75.11% |
| 5 Years | 25.15 | 33.0899 | 5.12 | 17.53 | 1,020,000 | -18.89 | -75.11% |
Travere Therapeutics Description
| Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. |
